http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005097137-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8c0982b0f02b1ed6d20a315370a3a3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_283c3294b52dc7ec6b88039fbc7be613
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-233
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-22
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-233
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
filingDate 2005-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50fc2d097e440d4954edd206b338e313
publicationDate 2006-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005097137-A3
titleOfInvention Advanced quinazoline based protein kinase inhibitors
abstract Hydroxy containing quinazoline based derivatives have enhanced and unexpected drug properties as inhibitors of protein kinases and are useful in treating disorders related to abnormal protein kinase activities such as cancer.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9353123-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9353122-B2
priorityDate 2004-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5492915-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5362743-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9633980-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6169088-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002091130-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5770599-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9210
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397482

Total number of triples: 40.